Biopharma

BD Launches Portable Antigen Test to Detect SARS-CoV-2 in 15 Minutes

NEW JERSEY BUSINESS MAGAZINE

BD (Becton, Dickinson and Company), a Franklin Lakes-based global medical technology company, announced that the U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA) for a rapid, point-of-care, SARS-CoV-2 diagnostic test for use with its broadly available BD Veritor™ Plus System. The launch of this new assay that delivers results in 15 minutes on an easy-to-use, highly portable …

PTC Therapeutics taps experimental cancer drug for new COVID-19 trial

Ben Adams | Fierce Biotech

PTC Therapeutics is throwing its hat in the ring for a potential reworked pipeline med against COVID-19. The biopharma, which has been focused on rare diseases, is tapping its early-stage cancer drug, currently in a test for certain leukemias, to see whether it can help patients afflicted with the disease. It is any day now kick-starting a phase 2/3 trial …

New Jersey Solutions For Cell And Gene Development and Manufacturing

Louis Garguilo | Outsourced Pharma

New Jersey’s first university-based, cell-and-gene-therapy development and manufacturing innovation center for-hire, was founded on the answers to these questions of the biopharma industry: What are your main challenges in manufacturing gene and cell therapy products? What are your challenges in recruiting talent? What do you need to effectively train your current employees? Answers poured in pre-establishment of the center from …

China-Based WuXi Biologics Selects Cranbury, New Jersey for Third U.S. Clinical Manufacturing Campus

Area Development News Desk | Area Development

WuXi Biologics, a China-based global company with leading open-access biologics technology platforms, signed a 10-year lease for a clinical manufacturing facility in Cranbury, New Jersey. This news follows WuXi Biologics’ recent purchase of land to build a new 107,000-square-foot clinical and commercial manufacturing facility in Worcester, Massachusetts, and the lease of a 33,000-square-foot site to establish a process development lab …

Merck Does Deals to Develop Coronavirus Vaccines, Drug

Jared S. Hopkins | The Wall Street Jounrnal

Big drugmaker Merck MRK -0.36%  & Co. said it is working on two potential vaccines and an experimental drug against the coronavirus, joining rivals in the frantic search for medicines. Merck, one of the world’s largest pharmaceutical companies by sales, said Tuesday it is acquiring one experimental vaccine as part of the purchase of its Austrian maker, while partnering in …

World’s First SARS-CoV-2 Serology Test Detects Neutralizing Antibodies Without Containment Facility or Specimen

HospiMedica

Researchers have developed the world’s first serological coronavirus detection system that allows for rapid detection of neutralizing antibodies (NAbs) present in the serum of COVID-19 patients without the need for live biological materials and biocontainment facility. GenScript Biotech Corporation (Piscataway, NJ, USA), Duke-NUS Medical School, and the Diagnostics Development Hub (DxD) at Singapore’s Agency for Science, Technology and Research (A*STAR) …

NJIT to start programs in cell and gene therapy

David Hutter | NJBIZ

The New Jersey Institute of Technology will collaborate with the New Jersey Innovation Institute, an NJIT corporation, to offer a professional science master’s degree program and professional graduate certificate in the rapidly expanding field of cell and gene therapy. Students be able to begin taking the 30-credit master’s degree in spring 2020 as part of NJIT’s Department of Chemistry and …

RU–Camden, Rowan University to receive $898K for scientific research

NJBIZ STAFF | NJBIZ

Rutgers University–Camden and Rowan University have been awarded $898,709 for their pharmacology, physiology and biological chemistry research programs from the U.S. Department of Health and Human Services National Institute of General Medical Sciences, U.S. Rep. Donald Norcross, D-1, announced Tuesday. Rutgers University–Camden will receive $453,072 for research into understanding the function of cisregulatory modules. Rowan University will receive $445,637 for …

PTC Therapeutics’ Move to Bristol-Myers Squibb Campus Showcases New Jersey’s Collaborative Ecosystem

NJEDA

TRENTON, N.J. (August 14, 2019) – When PTC Therapeutics signed a long-term lease agreement with Bristol-Myers Squibb (BMS) last week for space at the pharmaceutical giant’s Hopewell campus, it represented the latest chapter in the biopharmaceutical company’s 21-year history. In announcing the lease of 185,000 square of space from BMS, PTC Therapeutics officials noted that the biopharmaceutical company will expand …

WHAT CAN CHOOSE New Jersey DO FOR YOU

Relocation & Expansion Services

We provide customized RFI responses, demographics, detailed market assessments and other complimentary business relocation and expansion services. When your company chooses to grow in New Jersey, we also will help you publicize your good news.

Site Visits

We’ll make your property search seamless, so you find the site that best meets your relocation or expansion needs.

Economic Development Connections

Our public and private partners provide a wide range of services. From higher education research collaboration to regulatory and legal assistance to workforce training, they’ll ensure you have a smooth landing.

Carly Wronko
Marketing Manager
Tiffany Hess-Bennette
Creative Content Specialist